Literature DB >> 3396647

Delayed treatment with nerve growth factor reverses the apparent loss of cholinergic neurons after acute brain damage.

T Hagg1, M Manthorpe, H L Vahlsing, S Varon.   

Abstract

Previous studies have shown that the loss after brain injury of adult rat septal cholinergic neurons whose axons are transected can be prevented by immediate intraventricular nerve growth factor (NGF) administration. This loss of axotomized neurons may be due to a reduction in detectability of neurotransmitter-related enzyme rather than to neuronal death. Here we report that NGF treatment, started after most of the neurons were no longer detectable (i.e., 1, 2, and 3 weeks), induced a dramatic reappearance of the apparently lost cholinergic neurons. These results may have important implications for potential trophic factor treatments of CNS trauma and neurodegenerative diseases, such as Alzheimer's dementia, which are characterized by chronic and progressive losses in the function of specific sets of neurons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396647     DOI: 10.1016/0014-4886(88)90013-1

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  27 in total

1.  Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation.

Authors:  T T Yeo; J Chua-Couzens; L L Butcher; D E Bredesen; J D Cooper; J S Valletta; W C Mobley; F M Longo
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

2.  Molecular simulation of the binding of nerve growth factor peptide mimics to the receptor tyrosine kinase A.

Authors:  Marco Berrera; Antonino Cattaneo; Paolo Carloni
Journal:  Biophys J       Date:  2006-06-23       Impact factor: 4.033

3.  Neurotrophic factors rescue basal forebrain cholinergic neurons and improve performance on a spatial learning test.

Authors:  Yu-Shang Lee; Andalib Danandeh; Janie Baratta; Ching-Yi Lin; Jen Yu; Richard T Robertson
Journal:  Exp Neurol       Date:  2013-09-07       Impact factor: 5.330

Review 4.  Experimental neurotrophic factor therapy leads to cortical synaptic remodeling and compensates for behavioral deficits.

Authors:  A C Cuello
Journal:  J Psychiatry Neurosci       Date:  1997-01       Impact factor: 6.186

5.  Axotomy-induced neurotrophic withdrawal causes the loss of phenotypic differentiation and downregulation of NGF signalling, but not death of septal cholinergic neurons.

Authors:  Oscar M Lazo; Jocelyn C Mauna; Claudia A Pissani; Nibaldo C Inestrosa; Francisca C Bronfman
Journal:  Mol Neurodegener       Date:  2010-01-19       Impact factor: 14.195

6.  Loss of cholinergic phenotype in septohippocampal projection neurons: relation to brain versus peripheral IL-2 deficiency.

Authors:  Danielle M Meola; Zhi Huang; Michael King; John M Petitto
Journal:  Neurosci Lett       Date:  2013-02-13       Impact factor: 3.046

7.  Disruption of a single allele of the nerve growth factor gene results in atrophy of basal forebrain cholinergic neurons and memory deficits.

Authors:  K S Chen; M C Nishimura; M P Armanini; C Crowley; S D Spencer; H S Phillips
Journal:  J Neurosci       Date:  1997-10-01       Impact factor: 6.167

8.  Bridging grafts and transient nerve growth factor infusions promote long-term central nervous system neuronal rescue and partial functional recovery.

Authors:  M H Tuszynski; F H Gage
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

9.  The vigilance-promoting drug modafinil counteracts the reduction of tyrosine hydroxylase immunoreactivity and of dopamine stores in nigrostriatal dopamine neurons in the male rat after a partial transection of the dopamine pathway.

Authors:  A Ueki; L Rosén; B Andbjer; U B Finnman; U Altamimi; A M Janson; M Goldstein; L F Agnati; K Fuxe
Journal:  Exp Brain Res       Date:  1993       Impact factor: 1.972

10.  Effect of nerve growth factor on delayed neuronal death after cerebral ischaemia.

Authors:  K Tanaka; T Tsukahara; N Hashimoto; N Ogata; Y Yonekawa; T Kimura; T Taniguchi
Journal:  Acta Neurochir (Wien)       Date:  1994       Impact factor: 2.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.